肥胖,NAFLD和动脉样硬化心血管疾病之间的病理生理学关联
概括
肥胖,非酒精性脂肪性肝病 (NAFLD) 和心血管疾病都有共同的路径. 了解这些联系可以帮助开发针对多种机制的新疗法,以获得更好的健康结果.
科学领域:
- 代谢疾病 代谢疾病
- 心血管健康 心血管健康
- 肝脏病理生理学肝脏病理生理学
背景情况:
- 肥胖,非酒精性脂肪肝 (NAFLD) 和动脉样硬化心血管疾病 (ASCVD) 是重要的公共卫生问题.
- 流行病学数据显示,肥胖,NAFLD和ASCVD之间存在很强的相关性.
- 肥胖是NAFLD的主要风险因素,这两种情况都会增加ASCVD风险.
研究的目的:
- 探索与肥胖,NAFLD和ASCVD相关的共享病理生理机制.
- 突出机制主义观点对于开发有效干预措施的重要性.
- 讨论如何针对多个途径可以打破从肥胖到ASCVD的事件链.
主要方法:
- 审查当前的科学文献,重点关注肥胖,NAFLD和ASCVD之间的相互作用.
- 分析共享的病理生理机制,包括胰岛素耐药性,失脂症,炎症和氧化应激.
- 检查针对多种机制的近期治疗策略,例如GLP1受体激动剂.
主要成果:
- 肥胖会引发多种病理生理变化,包括胰岛素耐药性,脂质不良,炎症,氧化应激和肠道失调.
- NAFLD加剧了这些变化,导致ASCVD的发展和进展.
- 新兴的多目标疗法在减肥和改善代谢综合征并发症方面表现有前途.
结论:
- 像胰岛素抵抗,炎症和内皮功能障碍这样的共享机制是肥胖-NAFLD-ASCVD轴的核心.
- 对这些机制的更深入的理解对于开发新的多目标治疗方法至关重要.
- 同时解决这些途径的干预措施提供了一个有希望的策略,以减轻不良健康后果.
相关概念视频
Obesity
498
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
498
Inflammation
53.4K
Overview
53.4K
Overview of Lipid Metabolism
1.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.5K
Cholesterol: Significance and Regulation
544
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
544
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
91
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
91
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K


